BioGaia Logo

BioGaia

A healthcare and biotechnology company developing clinically proven probiotic products.

BIOG | ST

Overview

Corporate Details

ISIN(s):
SE0000470395 (+2 more)
LEI:
549300UBUJOY2L7TT361
Country:
Sweden
Address:
Box 3242, 103 64 Stockholm

Description

BioGaia is a healthcare and biotechnology company that is a world leader in probiotics. A pioneer in microbiome research for over 30 years, the company develops, markets, and sells a range of clinically proven probiotic products. Its portfolio is centered on its patented probiotic strain, Lactobacillus reuteri. These products, typically offered as food supplements, are designed to support the health and well-being of consumers at all stages of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-10-17 08:00
BioGaias resultat för tredje kvartalet överstiger marknadens förväntningar
Swedish 130.6 KB
2022-07-22 08:00 Swedish 1010.7 KB
2022-07-22 08:00 English 1005.9 KB
2022-07-14 08:00
BioGaia’s result for second quarter to exceed market expectations
English 145.9 KB
2022-07-14 08:00
BioGaias resultat för andra kvartalet överstiger marknadens förväntningar
Swedish 60.9 KB
2022-05-31 08:00
New number of shares and votes in BioGaia AB (publ)
English 113.8 KB
2022-05-31 08:00
Förändrat antal aktier och röster i BioGaia AB (publ)
Swedish 103.0 KB
2022-05-24 11:18 English 34.4 KB
2022-05-20 14:44 English 34.0 KB
2022-05-17 08:00
BioGaia startar egen distribution i Kanada
Swedish 149.8 KB
2022-05-17 08:00
BioGaia starts its own distribution in Canada
English 158.2 KB
2022-05-06 13:00
Avstämningsdag för aktieuppdelning (split) i BioGaia AB (publ) fastställd till …
Swedish 149.3 KB
2022-05-06 13:00
Record date for share split in BioGaia AB (publ) determined as 19 May 2022
English 115.0 KB
2022-05-06 08:00 Swedish 850.4 KB
2022-05-06 08:00 English 835.1 KB

Automate Your Workflow. Get a real-time feed of all BioGaia filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioGaia

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioGaia via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-08 Barbro Fridén Other Buy 188 19,627.20 SEK
2024-09-13 Linda Hägglund Other Sell 2,000 233,800.00 SEK
2024-09-12 Linda Hägglund Other Sell 994 115,502.80 SEK
2024-09-12 Linda Hägglund Other Sell 6 697.80 SEK
2024-06-10 Outi Armstrong Other Buy 1,000 125,400.00 SEK
2023-08-02 Anthon Jahreskog Other Buy 481 51,515.10 SEK
2023-08-02 Anthon Jahreskog Other Buy 169 18,083.00 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.